The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Exercise of Options & Total Voting Rights

6 Feb 2017 17:25

RNS Number : 1620W
CVS Group plc
06 February 2017
 

6 February 2017

 

CVS Group plc

("CVS" or the "Company")

 

Exercise of Options and Total Voting Rights

CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, announces that 19,587 ordinary shares of 0.2 pence each ("Ordinary Shares") (the "SAYE Shares") were issued on 2 February 2017 as a result of the exercise of employee share options, in connection with the Company's 2013/2016 Save As You Earn Scheme.

 

The SAYE Shares rank pari passu with all existing Ordinary Shares. The issue of the SAYE Shares has been satisfied via the Company's block listing which was announced on 19 December 2016.

 

The Company also announces that 2,277 Ordinary Shares of 0.2 pence each (the "New Shares") were allotted on 2 February 2017 as a result of the exercise of employee share options by former employees, in connection with the Company's 2014/2017 Save As You Earn Scheme and the Company's 2015/2018 Save As You Earn Scheme. Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 13 February 2017.

 

Following issue of the SAYE and New Shares, the Company's total issued share capital will consist of 63,851,424 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of SAYE Shares, the total number of voting rights in the Company is 63,851,424. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Contacts:

 

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director

 

Tel: 01379 644 288

 

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Liz Yong

James Hopton

Tel: 020 7496 3000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELLFFDFIIRIID

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.